Pmd150 - Expensive Combined Therapies for Rare Diseases Are Not Always What They Seem: An Economic Feasibility Audit

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1599
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV